Top entities: Rachel Haurwitz, Levi & Korsinsky, Joseph E. Levi.

What category does this event fall under?

Regulatory — classified as class action lawsuit.

What is the sentiment of coverage?

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

What were the key actions taken?

Levi & Korsinsky notified investors of lawsuit Rachel Haurwitz · Levi & Korsinsky filed complaint Rachel Haurwitz

Is this event still developing?

This event is archived — the story has concluded and this page is a final snapshot.

Regulatory class action lawsuit

Caribou Biosciences Class Action Lawsuit

Q: When did this event occur?

First reported Feb 04, 2025; last updated Feb 14, 2025.

Q: What is the market impact?

General. The market is impacted by the potential for significant losses for investors in Rachel Haurwitz due to alleged securities fraud.

Analysis based on 10 articles · First reported Feb 04, 2025 · Last updated Feb 14, 2025

Sentiment

-50

Attention

Articles

Market Impact

General

Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

Market Impact

The market is impacted by the potential for significant losses for investors in Rachel Haurwitz due to alleged securities fraud. The lawsuit could lead to a decline in Rachel Haurwitz' stock value and raise concerns about the transparency of clinical trial results and financial disclosures in the biotechnology sector.

Biotechnology Legal Services

Event Summary

Levi & Korsinsky has initiated a class action securities lawsuit against Rachel Haurwitz, alleging that the company made false and misleading statements to investors between July 14, 2023, and July 16, 2024. The complaint claims that Rachel Haurwitz overstated the safety, efficacy, and durability of its product CB-010, as well as its overall clinical results and commercial prospects. Additionally, the lawsuit alleges that Rachel Haurwitz concealed significant risks of insufficient cash and liquidity to fund its operations. Investors who suffered losses during this period have until February 24, 2025, to request to be appointed as lead plaintiff.

Key Actions

100 Levi & Korsinsky notified investors of lawsuit Rachel Haurwitz

95 Levi & Korsinsky filed complaint Rachel Haurwitz

Entities Involved

priv

Rachel Haurwitz

Rachel Haurwitz is the defendant in a class action securities lawsuit, facing allegations of making false and misleading statements regarding its product CB-010 and its financial stability. This event is expected to have a significant negative impact on Rachel Haurwitz' stock price and reputation.

Importance 100.0 Sentiment -70.0

priv

Levi & Korsinsky

Importance 0.0 Sentiment 0.0

per

Joseph E. Levi

Importance 0.0 Sentiment 0.0

Relationships

Levi & Korsinsky related ↔ Joseph E. Levi

ERGEN INTELLIGENCE

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard